Pressmeddelande

Shares subscribed by board and management in Cline's ongoing rights issue

Cision Publicerad: 10 Jul 2023 11:26

Series A shares are subscribed to in the ongoing rights issue, which runs until July 12.

Acting CEO Hanne Evenbratt and board member Patrik Sundh subscribe for Series A shares in Cline's ongoing rights issue. Hanne subscribes to 312,500 Series A shares and Patrik 650,000 Series A shares, for a total of SEK 231,000.

These subscriptions of shares are in addition to the previously announced board members' subscription of Series B shares, details can be found in Cline’s memorandum. Through these subscriptions, the board and management show their continued trust and foundational faith in Cline's future prospects.

The last day for subscription is July 12, 2023.

For more information, please contact:

Hanne Evenbratt, Interim CEO

Email: [email protected]

Phone: +46 704 88 79 23

Bifogade filer

Releasehttps://mb.cision.com/Main/12114/3802830/2181782.pdf

Nyheter om Cline Scientific

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!